CN Stock MarketDetailed Quotes
300039 Shanghai Kaibao Pharmaceutical
- 6.56
- -0.17-2.53%
Market Closed Nov 15 15:00 CST
6.86BMarket Cap19.70P/E (TTM)
6.78High6.50Low262.85KlotVolume6.70Open6.73Pre Close175.27MTurnover2.87%Turnover Ratio20.96P/E (Static)1.05BShares7.7852wk High1.78P/B6.02BFloat Cap4.9052wk Low8.08Limit Up916.93MShs Float18.28Historical High5.38Limit Down4.16%Amplitude2.60Historical Low0.10Dividend TTM6.67Avg Price143.70KlotAsk1.52%Div YieldTTM100Lot Size113.90KlotBid
Shanghai Kaibao Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 6.62%1.35B | 16.58%948.77M | 35.14%497.22M | 46.52%1.84B | 36.25%1.27B | 17.38%813.8M | 13.13%367.92M | 5.54%1.26B | 1.50%932.67M | 14.03%693.29M |
| Refunds of taxes and levies | -77.86%765.66K | ---- | --8.18 | 73.06%3.46M | --3.46M | ---- | --0 | 161.70%2M | ---- | ---- |
| Net deposit increase | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in borrowings from central bank | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in placements from other financial institutions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received from interests, fees and commissions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in repurchase business capital | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Premiums received from original insurance contracts | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net cash received from reinsurance business | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in deposits from policyholders | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in funds disbursed | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net cash received from trading securities | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other operating activities | -79.09%32.13M | -83.20%30.53M | -97.65%2.75M | 10.08%94.91M | 101.90%153.65M | 244.61%181.79M | 14.05%117.08M | 12.54%86.22M | 72.81%76.1M | 17.18%52.75M |
| Cash inflows from operating activities | -2.80%1.39B | -1.64%979.3M | 3.09%499.97M | 44.23%1.94B | 41.54%1.43B | 33.45%995.59M | 13.35%485M | 6.06%1.35B | 4.68%1.01B | 14.25%746.04M |
| Goods services cash paid | 63.70%337.41M | 193.01%194.42M | 168.38%138.78M | 134.57%282.86M | 75.68%206.12M | -55.85%66.35M | -21.29%51.71M | -28.15%120.59M | -28.19%117.33M | 46.22%150.3M |
| Staff behalf paid | -4.13%115.82M | -1.74%81.09M | 1.25%39.69M | 4.81%178.98M | -30.19%120.81M | -35.93%82.52M | 2.52%39.2M | 10.72%170.76M | 6.77%173.05M | 24.31%128.8M |
| All taxes paid | 0.26%205.98M | -2.54%160.03M | -13.71%91.42M | 76.76%258.88M | 84.31%205.45M | 98.67%164.2M | 150.63%105.94M | -7.25%146.47M | -12.15%111.47M | -7.74%82.65M |
| Net loan and advance increase | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net deposit in central bank and institutions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net lend capital | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid for fees and commissions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid for indemnity of original insurance contract | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Policy dividend cash paid | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid relating to other operating activities | -22.48%469.43M | -18.01%412.69M | -24.75%157.14M | 57.57%838.13M | 63.39%605.52M | 102.40%503.35M | 7.30%208.84M | -19.80%531.9M | -9.30%370.61M | -8.67%248.7M |
| Cash outflows from operating activities | -0.81%1.13B | 3.89%848.23M | 5.26%427.03M | 60.75%1.56B | 47.31%1.14B | 33.74%816.43M | 19.03%405.69M | -15.17%969.71M | -10.28%772.46M | 7.42%610.44M |
| Net cash flows from operating activities | -10.61%259.19M | -26.84%131.07M | -8.03%72.94M | 1.66%382.66M | 22.70%289.95M | 32.13%179.16M | -8.90%79.31M | 198.56%376.42M | 129.99%236.32M | 60.04%135.59M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -25.29%1.02B | -34.57%659M | 80.95%556.09M | 15.37%1.97B | -34.14%1.36B | -28.33%1.01B | -54.45%307.32M | -28.63%1.7B | 56.83%2.07B | 33.65%1.41B |
| Cash received from returns on investments | -6.08%4.22M | -54.12%1.64M | -54.84%1.14M | 277.22%11.63M | 80.30%4.49M | 302.82%3.58M | 2,470.37%2.52M | -7.68%3.08M | 22.54%2.49M | -47.52%888.53K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --884.96 | --884.96 | --884.96 | -89.29%28.82K | ---- | ---- | --0 | 75.17%269K | 4,530.32%909.6K | 25,511.68%964.95K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other investing activities | -90.76%34.19M | ---- | -99.99%20K | -34.67%380.21M | -8.03%370M | 3,252.10%335.21M | 2,400.00%250M | 227.26%582M | 180.38%402.29M | --10M |
| Cash inflows from investing activities | -39.21%1.05B | -50.91%660.64M | -0.46%557.25M | 2.98%2.36B | -29.80%1.73B | -5.02%1.35B | -18.43%559.84M | -10.88%2.29B | 68.96%2.47B | 34.56%1.42B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 727.18%137.7M | 815.04%137.1M | -81.96%957.97K | -8.03%29.08M | 469.57%16.65M | 469.14%14.98M | 3,120.82%5.31M | -25.69%31.62M | -82.35%2.92M | -55.98%2.63M |
| Cash paid to acquire investments | -27.92%999.2M | -28.95%641.39M | 97.80%526.49M | 19.30%1.98B | -34.94%1.39B | -39.59%902.71M | -65.03%266.17M | -29.53%1.66B | 62.39%2.13B | 41.85%1.49B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Impawned loan net increase | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid relating to other investing activities | -89.83%34.2M | ---- | --0 | -37.94%549.19M | -37.15%336.25M | --315M | --100M | 264.94%885M | 311.54%535M | ---- |
| Cash outflows from investing activities | -32.66%1.17B | -36.85%778.5M | 41.99%527.44M | -0.72%2.56B | -34.83%1.74B | -17.65%1.23B | -51.21%371.48M | -2.93%2.57B | 82.95%2.67B | 41.30%1.5B |
| Net cash flows from investing activities | -2,543.01%-116.44M | -204.11%-117.86M | -84.18%29.81M | 30.40%-198.63M | 97.77%-4.41M | 241.83%113.21M | 350.96%188.37M | -241.73%-285.37M | -5,416.96%-197.78M | -1,172.11%-79.82M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash from borrowing | --2.99M | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | --84.18K |
| Cash inflows from financing activities | --2.99M | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | --84.18K |
| Borrowing repayment | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Dividend interest payment | 66.69%104.61M | 66.67%104.6M | --0 | 20.00%62.76M | 20.00%62.76M | 20.00%62.76M | --0 | 65.27%52.3M | 66.21%52.3M | 66.21%52.3M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash payments relating to other financing activities | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash outflows from financing activities | 66.69%104.61M | 66.67%104.6M | --0 | 20.00%62.76M | 20.00%62.76M | 20.00%62.76M | --0 | -24.61%52.3M | -22.16%52.3M | -22.16%52.3M |
| Net cash flows from financing activities | -61.93%-101.62M | -66.67%-104.6M | --0 | -20.00%-62.76M | -20.00%-62.76M | -20.19%-62.76M | --0 | 24.61%-52.3M | 22.16%-52.3M | 22.28%-52.22M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | -81.54%41.12M | -139.80%-91.38M | -61.61%102.75M | 213.00%121.27M | 1,718.23%222.79M | 6,348.63%229.6M | 2,115.61%267.68M | 244.58%38.75M | -135.05%-13.77M | -68.39%3.56M |
| Add:Begin period cash and cash equivalents | 38.56%435.75M | 38.56%435.75M | 38.56%435.75M | 14.05%314.48M | 14.05%314.48M | 14.05%314.48M | 14.05%314.48M | -8.86%275.73M | -8.86%275.73M | -8.86%275.73M |
| End period cash equivalent | -11.24%476.87M | -36.71%344.37M | -7.50%538.5M | 38.56%435.75M | 105.09%537.27M | 94.81%544.08M | 102.27%582.16M | 14.05%314.48M | -23.36%261.97M | -10.99%279.3M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data